What can genetics tell us about the cause of fixed airflow obstruction?

Clinical and Experimental Allergy

Volumn 42, Issue 8, 2012, Pages 1176-1182

  Wain, L V ^a   Artigas, M Soler ^a   Tobin, M D ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

COPD; Genetics; Genome wide association studies; Lung function

Indexed keywords

ADAM PROTEIN; EXTRACELLULAR SUPEROXIDE DISMUTASE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 126; GELATINASE B; GLUTATHIONE TRANSFERASE M1; INTERSTITIAL COLLAGENASE; LYMPHOTOXIN; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE 15; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; RETINOIC ACID RECEPTOR BETA; SERINE PROTEINASE INHIBITOR; SEROTONIN 4 RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

AIRWAY OBSTRUCTION; ASTHMA; AUTOIMMUNE DISEASE; BREAST CANCER; BREATHING DISORDER; CANCER RISK; CHROMOSOME 15Q; CHROMOSOME 2Q; CHROMOSOME 6; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEACETYLATION; DNA METHYLATION; EPIGENETICS; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; GROWTH RETARDATION; HERITABILITY; HUMAN; HUMAN GENOME; LUNG CANCER; LUNG FUNCTION; LUNG LAVAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; META ANALYSIS (TOPIC); MORPHOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; RESPIRATORY TRACT ALLERGY; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETON MALFORMATION; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; VASODILATATION;

ANIMALS; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84864010981     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.03967.x     Document Type: Review

References (77)

1. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-55.
2. Beck GJ, Doyle CA, Schachter EN. Smoking and lung function. Am Rev Respir Dis 1981; 123:149-55.
3. Silverman EK, Speizer FE. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 1996; 80:501-22.
4. Hall IP. How will genetic approaches assist in the management of respiratory diseases?. Curr Opin Pharmacol 2009; 9:256-61.
5. Marciniak SJ, Lomas DA. What can naturally occurring mutations tell us about the pathogenesis of COPD?. Thorax 2009; 64:359-64.
6. Larson RK, Barman ML. The familial occurrence of chronic obstructive pulmonary disease. Ann Intern Med 1965; 63:1001-8.
7. Tager I, Tishler PV, Rosner B, Speizer FE, Litt M. Studies of the familial aggregation of chronic bronchitis and obstructive airways disease. Int J Epidemiol 1978; 7:55-62.
8. Lebowitz MD, Knudson RJ, Burrows B. Family aggregation of pulmonary function measurements. Am Rev Respir Dis 1984; 129:8-11.
9. Gottlieb DJ, Wilk JB, Harmon M et al. Heritability of longitudinal change in lung function. The Framingham study. Am J Respir Crit Care Med 2001; 164:1655-9.
10. Lewitter FI, Tager IB, McGue M, Tishler PV, Speizer FE. Genetic and environmental determinants of level of pulmonary function. Am J Epidemiol 1984; 120:518-30.
11. Palmer LJ, Knuiman MW, Divitini ML et al. Familial aggregation and heritability of adult lung function: results from the Busselton Health Study. Eur Respir J 2001; 17:696-702.
12. Wilk JB, Djousse L, Arnett DK et al. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet Epidemiol 2000; 19:81-94.
13. Burton PR, Tobin MD, Hopper JL. Key concepts in genetic epidemiology. Lancet 2005; 366:941-51.
14. Silverman EK, Palmer LJ, Mosley JD et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002; 70:1229-39.
15. Palmer LJ, Celedon JC, Chapman HA, Speizer FE, Weiss ST, Silverman EK. Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum Mol Genet 2003; 12:1199-210.
16. DeMeo DL, Celedon JC, Lange C et al. Genome-wide linkage of forced mid-expiratory flow in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:1294-301.
17. DeMeo D, Mariani T, Lange C et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Proc 2006; 3:502.
18. Zhu G, Warren L, Aponte J et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med 2007; 176:167-73.
19. Hall IP, Lomas DA. The genetics of obstructive lung disease: big is beautiful. Thorax 2010; 65:760-1.
20. Castaldi PJ, Cho MH, Cohn M et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet 2010; 19:526-34.
21. Smolonska J, Wijmenga C, Postma DS, Boezen HM. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am J Respir Crit Care Med 2009; 180:618-31.
22. Obeidat M, Wain LV, Shrine N et al. A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample. PLoS ONE 2011; 6:e19382.
23. Silverman EK, Vestbo J, Agusti A et al. Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD 2011; 8:121-35.
24. Ioannidis JP. Why most published research findings are false. PLoS Med 2005; 2:e124.
25. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96:434-42.
26. McCarthy MI, Abecasis GR, Cardon LR et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9:356-69.
27. Soler Artigas M, Wain LV, Tobin MD. Genome-wide association studies in lung disease. Thorax 2011; 2011:19.
28. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010; 42:45-52.
29. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat M et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010; 42:36-44.
30. Altshuler DM, Gibbs RA, Peltonen L et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467:52-8.
31. Soler Artigas M, Loth DW, Wain LV et al. Genome-wide association and large scale follow-up identifies 16 new loci influencing lung function. Nat Genet 2011; 43:1082-90.
32. Wilk JB, Chen TH, Gottlieb DJ et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009; 5:e1000429.
33. Castaldi PJ, Cho MH, Litonjua AA et al. The association of genome-wide significant spirometric loci with COPD susceptibility. Am J Respir Cell Mol Biol 2011; 45:1147-53.
34. Cho MH, Boutaoui N, Klanderman BJ et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010; 42:200-2.
35. Pillai SG, Ge D, Zhu G et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5:e1000421.
36. Soler Artigas M, Wain LV, Repapi E et al. Effect of 5 Genetic Variants Associated with Lung Function on the Risk of COPD, and their Joint Effects on Lung Function. Am J Respir Crit Care Med 2011; 184:786-95.
37. Loos RJ, Lindgren CM, Li S et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40:768-75.
38. Lango Allen H, Estrada K, Lettre G et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467:832-8.
39. Manzke T, Guenther U, Ponimaskin EG et al. 5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia. Science 2003; 301:226-9.
40. Hindorff LA, Sethupathy P, Junkins HA et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009; 106:9362-7.
41. Englert JM, Hanford LE, Kaminski N et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 2008; 172:583-91.
42. Celedon JC, Lange C, Raby BA et al. The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet 2004; 13:1649-56.
43. Matheson MC, Ellis JA, Raven J, Walters EH, Abramson MJ. Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease. J Hum Genet 2006; 51:196-203.
44. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:420-2.
45. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Nolte IM, Boezen HM. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population. Respir Res 2006; 7:89.
46. Yucesoy B, Kurzius-Spencer M, Johnson VJ et al. Association of cytokine gene polymorphisms with rate of decline in lung function. J Occup Environ Med 2008; 50:642-8.
47. Landi MT, Chatterjee N, Yu K et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009; 85:679-91.
48. Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009; 180:3-10.
49. Morin C, Sirois M, Echave V, Gomes MM, Rousseau E. Functional effects of 20-HETE on human bronchi: hyperpolarization and relaxation due to BKCa channel activation. Am J Physiol Lung Cell Mol Physiol 2007; 293:L1037-44.
50. Vang A, Mazer J, Casserly B, Choudhary G. Activation of endothelial BKCa channels causes pulmonary vasodilation. Vascul Pharmacol 2010; 53:122-9.
51. Moriguchi T, Haraguchi K, Ueda N, Okada M, Furuya T, Akiyama T. DREG, a developmentally regulated G protein-coupled receptor containing two conserved proteolytic cleavage sites. Genes Cells 2004; 9:549-60.
52. Jongepier H, Boezen HM, Dijkstra A et al. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 2004; 34:757-60.
53. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Schouten JP, Boezen HM. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005; 172:329-33.
54. Van Eerdewegh P, Little RD, Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002; 418:426-30.
55. Chazaud C, Dolle P, Rossant J, Mollard R. Retinoic acid signaling regulates murine bronchial tubule formation. Mech Dev 2003; 120:691-700.
56. Massaro GD, Massaro D, Chan WY et al. Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli. Physiol Genomics 2000; 4:51-7.
57. Yang J, Liu X, Yue G, Adamian M, Bulgakov O, Li T. Rootletin, a novel coiled-coil protein, is a structural component of the ciliary rootlet. J Cell Biol 2002; 159:431-40.
58. Makrygiannakis D, Hermansson M, Ulfgren AK et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008; 67:1488-92.
59. Bourbeau J, Johnson M. New and controversial therapies for chronic obstructive pulmonary disease. Proc 2009; 6:553-4.
60. Ito K, Ito M, Elliott WM et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005; 352:1967-76.
61. Vega RB, Matsuda K, Oh J et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004; 119:555-66.
62. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274:21491-4.
63. Park EJ, Roh J, Kim Y, Park K, Kim DS, Yu SD. PM 2.5 collected in a residential area induced Th1-type inflammatory responses with oxidative stress in mice. Environ Res 2011; 111:348-55.
64. Joos L, He JQ, Shepherdson MB et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002; 11:569-76.
65. Hunninghake GM, Cho MH, Tesfaigzi Y et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009; 361:2599-608.
66. Minematsu N, Nakamura H, Tateno H, Nakajima T, Yamaguchi K. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 2001; 289:116-19.
67. Zhou M, Huang SG, Wan HY, Li B, Deng WW, Li M. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China. Chin Med J (Engl) 2004; 117:1481-4.
68. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32:1-22.
69. Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med 2008; 5:e177.
70. Liu JZ, Tozzi F, Waterworth DM et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010; 42:436-40.
71. Thorgeirsson TE, Gudbjartsson DF, Surakka I et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 2010; 42:448-53.
72. Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 2010; 42:441-7.
73. DeMeo DL, Mariani T, Bhattacharya S et al. Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet 2009; 85:493-502.
74. Wain LV, Armour JA, Tobin MD. Genomic copy number variation, human health, and disease. Lancet 2009; 374:340-50.
75. Wacholder S, Hartge P, Prentice R et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med 2010; 362:986-93.
76. Talmud PJ, Hingorani AD, Cooper JA et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 2010; 340:b4838.
77. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61:935-9.